Form 8-K · Current report
News Corp 8-K, filed Sep 18, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000204
Summary
News Corp repurchased 54,641 Class A common shares for about US$1.65 million on September 17, 2026, under the 2025 repurchase program authorizing up to US$1 billion of its Class A and Class B common stock; cumulative purchases under that program total roughly US$483.4 million.
Key points
- News Corp repurchased 54,641 Class A common shares for about US$1,654,491 on September 17, 2026, at prices between US$30.00 and US$30.43.
- Cumulative buy-backs under the program stand at 12,067,301 shares for US$314,814,001.70, with roughly US$483.4 million of total consideration paid under the 2025 repurchase program.
- The 2025 repurchase program, authorized as of July 15, 2025, covers up to an aggregate US$1 billion of Nasdaq-listed Class A and Class B common stock, with Goldman Sachs & Co. LLC as broker and no ASX-listed CDIs to be repurchased.
- News Corp states the buy-back's purpose is to enhance shareholder value and that it requires no security holder approval.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.